<?xml version="1.0" encoding="UTF-8"?>
<p id="para310">Previous assessments have considered effects on HIV care in other crisis situations such as the post-election unrest in Kenya in 2007,
 <xref rid="bib22" ref-type="bibr">22</xref>, 
 <xref rid="bib23" ref-type="bibr">23</xref> during the Ebola epidemic in Guinea in 2014,
 <xref rid="bib24" ref-type="bibr">
  <sup>24</sup>
 </xref> in acute conflict areas in the Central African Republic and Yemen,
 <xref rid="bib25" ref-type="bibr">
  <sup>25</sup>
 </xref> and as a consequence of food insecurity.
 <xref rid="bib26" ref-type="bibr">
  <sup>26</sup>
 </xref> All assessments found substantial negative effects but also evidence of resilience and ability to successfully ensure access to ART drugs.
 <xref rid="bib25" ref-type="bibr">25</xref>, 
 <xref rid="bib26" ref-type="bibr">26</xref> By contrast with concern over negative effects of the COVID-19 pandemic, longer-term benefits might be seen because the crisis has led to simplifications to delivery of care, with multi-month dispensing and fewer clinic visits required per patient than previously, which in turn reduces costs and results in a similar health outcome.
 <xref rid="bib27" ref-type="bibr">
  <sup>27</sup>
 </xref>
</p>
